GLOBAL MORQUIO SYNDROME (MPS-IV) DRUG MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Morquio Syndrome (MPS-IV) Drug Market, By Product Type (Solid Dosage Form, Liquid Dosage Form), By Treatment (Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy, Others), By Disease Type (Morquio A, Morquio B), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

North America is expected to be the largest market for morquio syndrome (MPS-IV) drug market during the forecast period, accounting for over 43.7% of the market share in 2024. The North American region dominates the global morquio syndrome (MPS-IV) drug market with the presence of several top pharmaceutical companies and a large healthcare expenditure.
Asia Pacific market is expected to be the second-largest market for morquio syndrome (MPS-IV) drug market, accounting for over 25.2% of the market share in 2024. The Asia Pacific region, especially emerging countries like China and India, is witnessing the fastest growth in the morquio syndrome (MPS-IV) drug market. This is due to increasing research and development (R&D) activities, partnerships and agreements among key market players.
Europe market is expected to be the fastest-growing market for morquio syndrome (MPS-IV) drug market, with a share of 19% during the forecast period. The growth of the market in Europe is emerging as a hotspot at a rapid pace due to favorable policy support, infrastructure developments, and evolving customer preferences.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa